$60 Israeli blood test detects stage 2 to 4 lung cancer with 93% accuracy, study finds

A $60 blood test developed by researchers at Tel Aviv University detected stage 2 to 4 lung cancer with 93% accuracy, according to a study.

The test uses a simple chip and skips DNA sequencing. The researchers say the findings could help advance earlier cancer diagnosis and allow doctors to monitor treatment in real time.